SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8889459
Source:
http://linkedlifedata.com/resource/pubmed/id/8889459
Search
Subject
(
74
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0010346
,
umls-concept:C0025815
,
umls-concept:C0030685
,
umls-concept:C0054201
,
umls-concept:C0205177
,
umls-concept:C0391871
,
umls-concept:C0442027
,
umls-concept:C0680255
,
umls-concept:C1257890
,
umls-concept:C1283071
,
umls-concept:C1556085
,
umls-concept:C1963578
,
umls-concept:C2603343
pubmed:issue
9
pubmed:dateCreated
1997-1-14
pubmed:abstractText
Corticosteroids are effective in acute Crohn's disease (CD). The present study assessed the effectiveness and safety of oral pH-modified release budesonide (BUD) in patients with active CD in comparison with 6-methylprednisolone (MPred).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9000874
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Budesonide
,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids
,
http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone
,
http://linkedlifedata.com/resource/pubmed/chemical/Pregnenediones
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0954-691X
pubmed:author
pubmed-author:AndusTT
,
pubmed-author:BärUU
,
pubmed-author:BischoffS CSC
,
pubmed-author:CaesarII
,
pubmed-author:EweKK
,
pubmed-author:GierendMM
,
pubmed-author:GroteGG
,
pubmed-author:LochsHH
,
pubmed-author:SchölmerichJJ
,
pubmed-author:SchulzH JHJ
,
pubmed-author:TrommAA
,
pubmed-author:WeberAA
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
905-9
pubmed:dateRevised
2009-10-16
pubmed:meshHeading
pubmed-meshheading:8889459-Administration, Oral
,
pubmed-meshheading:8889459-Adult
,
pubmed-meshheading:8889459-Anti-Inflammatory Agents
,
pubmed-meshheading:8889459-Budesonide
,
pubmed-meshheading:8889459-Crohn Disease
,
pubmed-meshheading:8889459-Delayed-Action Preparations
,
pubmed-meshheading:8889459-Double-Blind Method
,
pubmed-meshheading:8889459-Drug Administration Schedule
,
pubmed-meshheading:8889459-Female
,
pubmed-meshheading:8889459-Glucocorticoids
,
pubmed-meshheading:8889459-Humans
,
pubmed-meshheading:8889459-Hydrogen-Ion Concentration
,
pubmed-meshheading:8889459-Male
,
pubmed-meshheading:8889459-Methylprednisolone
,
pubmed-meshheading:8889459-Middle Aged
,
pubmed-meshheading:8889459-Pregnenediones
,
pubmed-meshheading:8889459-Prospective Studies
,
pubmed-meshheading:8889459-Remission Induction
pubmed:year
1996
pubmed:articleTitle
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
pubmed:affiliation
Department of Internal Medicine, Universities of Regensburg.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study